AP249A - Anti-viral compounds. - Google Patents

Anti-viral compounds. Download PDF

Info

Publication number
AP249A
AP249A APAP/P/1991/000253A AP9100253A AP249A AP 249 A AP249 A AP 249A AP 9100253 A AP9100253 A AP 9100253A AP 249 A AP249 A AP 249A
Authority
AP
ARIPO
Prior art keywords
compound
formula
acetamido
group
glycero
Prior art date
Application number
APAP/P/1991/000253A
Other languages
English (en)
Other versions
AP9100253A0 (en
Inventor
Itzstein Laurence Mark Von
Wen-Yang Wu
Tho Van Phan
Basil Danylec
Betty Jin
Original Assignee
Biota Scient Management Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biota Scient Management Pty Ltd filed Critical Biota Scient Management Pty Ltd
Publication of AP9100253A0 publication Critical patent/AP9100253A0/xx
Application granted granted Critical
Publication of AP249A publication Critical patent/AP249A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
APAP/P/1991/000253A 1990-04-24 1991-04-23 Anti-viral compounds. AP249A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPJ980090 1990-04-24
AUPK289690 1990-10-19
AUPK453791 1991-02-11

Publications (2)

Publication Number Publication Date
AP9100253A0 AP9100253A0 (en) 1991-04-30
AP249A true AP249A (en) 1993-03-17

Family

ID=27157556

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1991/000253A AP249A (en) 1990-04-24 1991-04-23 Anti-viral compounds.

Country Status (37)

Country Link
US (2) US5360817A (bg)
EP (2) EP0526543B1 (bg)
JP (1) JP2944750B2 (bg)
KR (1) KR0169496B1 (bg)
CN (3) CN1036849C (bg)
AP (1) AP249A (bg)
AT (2) ATE406358T1 (bg)
AU (2) AU654815B2 (bg)
BG (1) BG62092B1 (bg)
CA (2) CA2291994C (bg)
CY (1) CY2186B1 (bg)
CZ (1) CZ288492B6 (bg)
DE (3) DE69128469T2 (bg)
DK (1) DK0526543T3 (bg)
ES (2) ES2313730T3 (bg)
FI (2) FI105478B (bg)
GR (1) GR3026225T3 (bg)
HK (2) HK1003834A1 (bg)
HU (2) HU219355B (bg)
IE (2) IE911372A1 (bg)
IL (1) IL97936A (bg)
LU (1) LU90468I2 (bg)
MY (1) MY107843A (bg)
NL (1) NL990030I2 (bg)
NO (3) NO302751B1 (bg)
NZ (1) NZ237936A (bg)
OA (1) OA09679A (bg)
PL (3) PL166918B1 (bg)
PT (1) PT97460B (bg)
RU (1) RU2119487C1 (bg)
SG (1) SG43170A1 (bg)
SI (1) SI9110745B (bg)
SK (1) SK282950B6 (bg)
UA (1) UA41252C2 (bg)
WO (1) WO1991016320A1 (bg)
YU (1) YU48741B (bg)
ZA (1) ZA913086B (bg)

Families Citing this family (132)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU659501B2 (en) * 1991-10-23 1995-05-18 Biota Scientific Management Pty Ltd Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
GB9126725D0 (en) * 1991-12-17 1992-02-12 Glaxo Group Ltd Process
GB9220241D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
GB9220327D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
GB9312531D0 (en) * 1993-06-17 1993-08-04 Glaxo Group Ltd Process
US5958973A (en) * 1993-09-03 1999-09-28 Gilead Sciences, Inc. Polyhydroxy benzoic acid derivatives and their use as neuraminidase inhibitors
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds
GB9400206D0 (en) * 1994-01-07 1994-03-02 Glaxo Group Ltd Chemical compound
AUPM354694A0 (en) * 1994-01-27 1994-02-17 Biota Scientific Management Pty Ltd Chemical compounds
US5453533A (en) * 1994-04-14 1995-09-26 The University Of Alabama At Birmingham Inhibitors of influenza virus neuraminidase and methods of making and using the same
US5985859A (en) * 1994-04-14 1999-11-16 The University Of Alabama Methods of inhibiting bacterial sialidase
JP3648740B2 (ja) * 1994-05-27 2005-05-18 ダイキン工業株式会社 ７位をフッ素で置換した２，３−ジデヒドロシアル酸およびその合成中間体
GB9410817D0 (en) * 1994-05-28 1994-07-20 Glaxo Group Ltd Medicaments
AUPM725794A0 (en) * 1994-08-03 1994-08-25 Biota Scientific Management Pty Ltd Chemical compounds
US5556963A (en) * 1994-08-05 1996-09-17 Oklahoma Medical Research Foundation Synthesis of 4-alkoxy-N-acetylneuraminic acid
GB9416365D0 (en) * 1994-08-12 1994-10-05 Glaxo Group Ltd Medicaments
US5512596A (en) * 1994-09-02 1996-04-30 Gilead Sciences, Inc. Aromatic compounds
US5475109A (en) * 1994-10-17 1995-12-12 Merck & Co., Inc. Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease
EP0976734B1 (en) * 1995-02-27 2005-09-28 Gilead Sciences, Inc. Selective inhibitors of viral or bacterial neuraminidase
CN101143859A (zh) * 1995-02-27 2008-03-19 吉里德科学公司 新颖化合物,其合成方法及治疗用途
BR9607098B8 (pt) * 1995-02-27 2014-11-18 Gilead Sciences Inc Composto e composição farmacêutica.
AU4259500A (en) * 1995-02-27 2000-08-31 Gilead Sciences, Inc. Novel compounds and methods for synthesis and therapy
US5866601A (en) * 1995-02-27 1999-02-02 Gilead Sciences, Inc. Carbocyclic compounds
US5602277A (en) * 1995-03-30 1997-02-11 Biocryst Pharmaceuticals, Inc. Substituted benzene derivatives useful as neuraminidase inhibitors
US5714509A (en) * 1995-05-03 1998-02-03 The University Of Alabama Inhibitors of bacterial sialidase and methods of making and using the same
EP0833825B1 (en) * 1995-05-19 2001-09-26 Biota Scientific Management Pty. Ltd. 6-carboxamido dihydropyran derivatives
GB9516276D0 (en) * 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
JPH0967270A (ja) * 1995-08-31 1997-03-11 Res Dev Corp Of Japan 水晶体混濁の予防および治療法、並びにそのための薬 剤
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
ATE238552T1 (de) 1996-03-01 2003-05-15 Biota Scient Management Verfahren zum nachweis von influenza-virus und dazu verwendbare verbindungen
US6093816A (en) 1996-06-27 2000-07-25 Isis Pharmaceuticals, Inc. Cationic lipids
PT823428E (pt) * 1996-07-22 2002-04-29 Sankyo Co Derivados do acido neuraminico sua preparacao e sua utilizacao em medicina
US6340702B1 (en) 1996-07-22 2002-01-22 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
US6451766B1 (en) 1996-07-22 2002-09-17 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
ATE239006T1 (de) * 1996-08-13 2003-05-15 Sankyo Co Verbindungen der neuraminsaeure
US6518438B2 (en) 1996-08-23 2003-02-11 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
US5859284A (en) 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
EP0882721A4 (en) * 1996-09-10 1999-12-22 Daikin Ind Ltd 4-SUBSTITUTED 2,7-DIDEOXY-7-FLUORO-2,3-DIDEHYDRO SIAL ACIDS
US5719020A (en) * 1996-09-25 1998-02-17 Oklahoma Medical Research Foundation 4,7-dialkoxy N-acetylneuraminic acid derivatives and methods for detection of influenza type A and B viruses in clinical specimens
US5994377A (en) 1996-10-21 1999-11-30 Gilead Sciences, Inc. Piperidine compounds
CA2268756A1 (en) * 1996-10-21 1998-04-30 Gilead Sciences, Inc. Piperidine compounds
KR20000068986A (ko) * 1996-11-14 2000-11-25 리차드웨드레이 신규 용도 화합물 및 그 제조방법
US5886213A (en) * 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds
JP3390965B2 (ja) 1997-09-12 2003-03-31 理化学研究所 糖結合スフィンゴシンを含有するポリマー化合物
US20040053999A1 (en) * 1997-09-17 2004-03-18 Bischofberger Norbert W. Novel compounds and methods for synthesis and therapy
AU747702B2 (en) * 1997-09-17 2002-05-16 Gilead Sciences, Inc. Compounds containing six-membered rings, processes for their preparation, and their use as medicaments
US20030129146A1 (en) * 1997-10-31 2003-07-10 Vincent Fischetti The use of bacterial phage associated lysing proteins for treating bacterial dental caries
TW477783B (en) * 1997-12-12 2002-03-01 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
EP1087938A1 (en) * 1998-04-23 2001-04-04 Abbott Laboratories Inhibitors of neuraminidases
EE200100027A (et) 1998-07-15 2002-06-17 Jomaa Hassan Fosfororgaanilised ühendid, neid sisaldav farmatseutiline preparaat ja nende kasutamine
US6303764B1 (en) 1998-09-24 2001-10-16 Zymetx, Inc. Synthesis of 4,7-dialkyl chromogenic glycosides of N-acetylneuraminic acids
US6664235B1 (en) 1999-08-20 2003-12-16 Riken Medicaments comprising sialic acid derivatives as active ingredients
US6420552B1 (en) 1999-09-10 2002-07-16 Zymetx, Inc. Syntheses of 4-alkyl chromogenic glycosides and 7-alkyl chromogenic glycosides of N-acetylneuraminic acids
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
AU2039301A (en) * 1999-10-19 2001-04-30 Abbott Laboratories Neuraminidase inhibitors
US6627396B1 (en) * 1999-10-28 2003-09-30 The Regents Of The University Of California Influenza sensor
CA2402081C (en) 2000-03-06 2015-09-22 University Of Kentucky Research Foundation A compound that selectively binds to cd123 and use thereof to kill hematologic cancer progenitor cells
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments
AUPR001000A0 (en) 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
US20030096281A1 (en) * 2001-09-14 2003-05-22 Ganesh Venkataraman Methods of making glycomolecules with enhanced activities and uses thereof
JP2006241024A (ja) * 2005-03-01 2006-09-14 Takashi Suzuki 新規シアル酸誘導体
AR060623A1 (es) 2006-04-27 2008-07-02 Astrazeneca Ab Compuestos derivados de 2-azetidinona y un metodo de preparacion
CN100471848C (zh) * 2006-06-05 2009-03-25 中国医学科学院医药生物技术研究所 一组长链烷氧烷基取代唾液酸衍生物及其制备方法
US20080063722A1 (en) * 2006-09-08 2008-03-13 Advanced Inhalation Research, Inc. Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
AU2008208865B2 (en) 2007-01-23 2013-01-24 Therapicon Srl Antiviral compounds
US20080194801A1 (en) * 2007-02-14 2008-08-14 Swanson Basil I Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses
US7981930B2 (en) * 2007-03-13 2011-07-19 Adamas Pharmaceuticals, Inc. Compositions and kits for treating influenza
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
JP2010524467A (ja) 2007-04-16 2010-07-22 モメンタ ファーマシューティカルズ インコーポレイテッド 規定の糖タンパク質産物および関連の方法
US7888337B2 (en) 2007-08-31 2011-02-15 Academia Sinica Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity
WO2009129305A2 (en) 2008-04-15 2009-10-22 Tsrl, Inc. Prodrugs of neuraminidase inhibitors
US8680020B2 (en) 2008-07-15 2014-03-25 Academia Sinica Glycan arrays on PTFE-like aluminum coated glass slides and related methods
US8993789B2 (en) 2008-11-28 2015-03-31 Cipla Limited Process for preparing zanamivir and intermediates for use in the process
TWI491416B (zh) 2008-12-24 2015-07-11 Daiichi Sankyo Co Ltd 吸入用乾燥粉末醫藥組成物
EP2228054A1 (en) 2009-03-13 2010-09-15 ITALFARMACO S.p.A. Riluzole aqueous suspensions
EP2427446B1 (en) * 2009-05-04 2016-03-30 National Research Council of Canada Inhibitors of sialidase or sialidase-like enzymes
EP2429991B1 (en) 2009-05-15 2014-09-10 Redx Pharma Limited Redox drug derivatives
CA2767453C (en) * 2009-07-15 2018-10-09 The University Of British Columbia Neuraminidase inhibitor compounds, compositions and methods for the use thereof as anti-virals
JP2012532894A (ja) * 2009-07-16 2012-12-20 グリフィス ユニバーシティ 抗インフルエンザ薬
IT1396620B1 (it) 2009-11-25 2012-12-14 Therapicon Srl Analoghi chimerici
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
JP2011136964A (ja) * 2009-12-28 2011-07-14 Gifu Univ ノイラミン酸誘導体、シアリダーゼ活性阻害剤及び抗インフルエンザ薬
MX2012011648A (es) 2010-04-07 2012-11-29 Momenta Pharmaceuticals Inc Glicanos de alta manosa.
WO2011130332A1 (en) 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
DK2568976T3 (en) 2010-05-10 2016-01-11 Academia Sinica Zanamivir-phosphonate congener with the anti-influenza activity, and determining the sensitivity oseltamivir in influenza viruses
CN101921251B (zh) * 2010-09-21 2011-10-05 仙居县圃瑞药业有限公司 扎那米韦中间体的精制工艺方法
CN102464640A (zh) * 2010-10-29 2012-05-23 江苏正大天晴药业股份有限公司 扎那米韦的制备方法
AT510585B1 (de) 2010-11-18 2012-05-15 Apeptico Forschung & Entwicklung Gmbh Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase
WO2012114350A1 (en) 2011-02-24 2012-08-30 Cadila Healthcare Limited Process for the preparation of zanamivir
US9170249B2 (en) 2011-03-12 2015-10-27 Momenta Pharmaceuticals, Inc. N-acetylhexosamine-containing N-glycans in glycoprotein products
WO2012142492A2 (en) * 2011-04-15 2012-10-18 University Of Georgia Research Foundation, Inc. Methods for inhibiting virus replication
KR101369584B1 (ko) 2011-04-19 2014-03-06 일양약품주식회사 페닐-이속사졸 유도체 및 그의 제조방법
GB2498080A (en) 2011-12-21 2013-07-03 Redx Pharma Ltd Derivatives of oseltamivir
WO2013106937A1 (en) * 2012-01-19 2013-07-25 The University Of British Columbia 3' equatorial-fluorine-substituted neuraminidase inhibitor compounds, compositions and methods for the use thereof as anti-virals
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
US9695244B2 (en) 2012-06-01 2017-07-04 Momenta Pharmaceuticals, Inc. Methods related to denosumab
WO2014031498A1 (en) 2012-08-18 2014-02-27 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
WO2014068265A1 (en) 2012-10-29 2014-05-08 Cipla Limited Antiviral phosphonate analogues and process for preparation thereof
US10450361B2 (en) 2013-03-15 2019-10-22 Momenta Pharmaceuticals, Inc. Methods related to CTLA4-Fc fusion proteins
US10464996B2 (en) 2013-05-13 2019-11-05 Momenta Pharmaceuticals, Inc. Methods for the treatment of neurodegeneration
WO2014210397A1 (en) 2013-06-26 2014-12-31 Academia Sinica Rm2 antigens and use thereof
US9981030B2 (en) 2013-06-27 2018-05-29 Academia Sinica Glycan conjugates and use thereof
CN103396957B (zh) * 2013-07-11 2015-08-19 中国海洋大学 一种来源于鲤链霉菌的海洋微生物多糖及其制备方法
CA2923579C (en) 2013-09-06 2023-09-05 Academia Sinica Human inkt cell activation using glycolipids with altered glycosyl groups
WO2015032357A1 (zh) * 2013-09-09 2015-03-12 中国科学院上海有机化学研究所 扎那米韦和拉那米韦的中间体及其合成方法
US20160257754A1 (en) 2013-10-16 2016-09-08 Momenta Pharmaceuticals Inc. Sialylated glycoproteins
JP6453050B2 (ja) * 2013-11-15 2019-01-16 国立大学法人富山大学 ２−デオキシ−２，３−ジデヒドロシアル酸誘導体およびその製造法
JP2017507118A (ja) 2014-01-16 2017-03-16 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ がんの処置および検出のための組成物および方法
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
CN106415244B (zh) 2014-03-27 2020-04-24 中央研究院 反应性标记化合物及其用途
EA201692111A1 (ru) 2014-05-12 2017-08-31 Глаксосмитклайн Интеллекчуал Проперти (№ 2) Лимитед Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
JP7062361B2 (ja) 2014-05-27 2022-05-06 アカデミア シニカ 抗ｈｅｒ２糖操作抗体群およびその使用
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
WO2015184004A1 (en) 2014-05-27 2015-12-03 Academia Sinica Anti-cd20 glycoantibodies and uses thereof
EP3149045B1 (en) 2014-05-27 2023-01-18 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
CA2950433A1 (en) 2014-05-28 2015-12-03 Academia Sinica Anti-tnf-alpha glycoantibodies and uses thereof
NL2013420B1 (en) * 2014-09-05 2016-09-27 Univ Griffith Antiviral agents and uses thereof.
EP3191500A4 (en) 2014-09-08 2018-04-11 Academia Sinica HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS
EP3210995B1 (en) 2014-10-24 2022-03-30 PeptiDream Inc. Hemagglutinin-binding peptide
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
EP3248005B1 (en) 2015-01-24 2020-12-09 Academia Sinica Novel glycan conjugates and methods of use thereof
CA3016170A1 (en) 2016-03-08 2017-09-14 Academia Sinica Methods for modular synthesis of n-glycans and arrays thereof
KR102588027B1 (ko) 2016-08-22 2023-10-12 초 파마 인크. 항체, 결합 단편 및 사용 방법
CN106520864A (zh) * 2016-09-28 2017-03-22 南京农业大学 一种酶法合成唾液酸类似物的方法及其应用
AU2018273411B2 (en) * 2017-05-25 2022-12-01 The Governors Of The University Of Alberta Methods of preventing or treating atherosclerosis with inhibitors of specific isoenzymes of human neuraminidase
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
WO2023119230A1 (en) 2021-12-22 2023-06-29 L'oreal Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use
WO2023118896A1 (en) 2021-12-23 2023-06-29 Subintro Limited Novel antiviral compositions comprising oleic acid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL287642A (bg) 1962-01-18

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HELVETICA CHIMICA ACTA, Vol. 69, 1986, pp. 1191-1204 *
LIEBIGS ANN. CHEM.: 1989, pp. 159-165 *

Also Published As

Publication number Publication date
FI924790A (fi) 1992-10-22
AU7533891A (en) 1991-12-12
NO302751B1 (no) 1998-04-20
FI105478B (fi) 2000-08-31
NO974670L (no) 1992-12-18
CZ288492B6 (en) 2001-06-13
NL990030I1 (nl) 1999-12-01
CN1036849C (zh) 1997-12-31
MY107843A (en) 1996-06-29
SI9110745A (en) 1997-04-30
CA2081356C (en) 2000-02-22
BG62092B1 (bg) 1999-02-26
PL167630B1 (pl) 1995-10-31
DE69128469T2 (de) 1998-06-04
RU2119487C1 (ru) 1998-09-27
AU654815B2 (en) 1994-11-24
GR3026225T3 (en) 1998-05-29
IE911372A1 (en) 1991-11-06
PL166918B1 (pl) 1995-07-31
CY2186B1 (en) 2002-11-08
CA2291994C (en) 2003-10-14
JPH05507068A (ja) 1993-10-14
ES2313730T3 (es) 2009-03-01
IE980526A1 (en) 2003-10-15
DE69128469D1 (de) 1998-01-29
EP0526543A1 (en) 1993-02-10
EP0526543A4 (en) 1993-04-21
EP0786458A3 (en) 1999-10-13
NZ237936A (en) 1997-08-22
EP0526543B1 (en) 1997-12-17
YU74591A (sh) 1994-06-24
SI9110745B (en) 2001-06-30
FI20001231A (fi) 2000-05-23
CN1091594C (zh) 2002-10-02
CN1057260A (zh) 1991-12-25
BG96978A (bg) 1993-12-24
ATE406358T1 (de) 2008-09-15
NO923944L (no) 1992-12-18
YU48741B (sh) 1999-09-27
HK1003834A1 (en) 1998-11-06
HK1010191A1 (en) 1999-06-17
EP0786458B1 (en) 2008-08-27
CA2291994A1 (en) 1991-10-25
FI924790A0 (fi) 1992-10-22
AP9100253A0 (en) 1991-04-30
DE19975068I1 (de) 2000-01-13
CN1143853C (zh) 2004-03-31
ES2113881T3 (es) 1998-05-16
AU7759091A (en) 1991-11-11
JP2944750B2 (ja) 1999-09-06
CN1150020A (zh) 1997-05-21
CS114591A3 (en) 1991-12-17
PT97460B (pt) 1999-01-29
PT97460A (pt) 1992-01-31
KR0169496B1 (ko) 1999-01-15
HU210717A9 (en) 1995-06-28
DK0526543T3 (da) 1998-08-24
DE69133604D1 (de) 2008-10-09
CN1184108A (zh) 1998-06-10
NL990030I2 (nl) 2000-02-01
WO1991016320A1 (en) 1991-10-31
NO974670D0 (no) 1997-10-09
SG43170A1 (en) 1997-10-17
UA41252C2 (uk) 2001-09-17
CA2081356A1 (en) 1991-10-25
IL97936A (en) 1995-12-08
ATE161253T1 (de) 1998-01-15
US5648379A (en) 1997-07-15
HUT61989A (en) 1993-03-29
OA09679A (en) 1993-05-15
HU9203180D0 (en) 1992-12-28
HU219355B (en) 2001-03-28
SK282950B6 (sk) 2003-01-09
LU90468I2 (fr) 2000-01-03
NO923944D0 (no) 1992-10-09
PL167192B1 (pl) 1995-08-31
EP0786458A2 (en) 1997-07-30
NO1999021I1 (no) 1999-09-17
DE19975068I2 (de) 2002-10-10
US5360817A (en) 1994-11-01
ZA913086B (en) 1992-12-30

Similar Documents

Publication Publication Date Title
AP249A (en) Anti-viral compounds.
AU659501B2 (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
AU774222B2 (en) Dimeric compounds and their use as inhibitors of neuraminidase
WO1995020583A1 (en) Derivatives of 2-deoxy-2,3-dehydro-n-acetylneuraminic acid (dana)
EP2123271A1 (en) Drug for treatment of influenza
Masuda et al. Synthesis and anti-influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives
US5639786A (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of α-D-neuraninic acid
WO1996004265A1 (en) 2,6-DIDEOXY-2,3-DIDEHYDRO-6-THIO DERIVATIVES OF α-D-NEURAMINIC ACID
JP3923081B2 (ja) ウイルスノイラミニダーゼ阻害剤としてのジヒドロピラン誘導体
JP3923081B6 (ja) ウイルスノイラミニダーゼ阻害剤としてのジヒドロピラン誘導体